Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1966 1
1971 1
1978 2
1980 1
1981 2
1982 1
1983 3
1984 4
1985 2
1987 3
1988 3
1990 2
1991 4
1992 4
1993 2
1994 4
1995 5
1996 6
1997 2
1998 3
1999 3
2000 1
2001 6
2002 6
2003 7
2004 4
2005 5
2006 9
2008 11
2009 10
2010 10
2011 11
2012 13
2013 12
2014 7
2015 7
2016 6
2017 5
2018 6
2019 4
2020 3
2021 4
2022 2
2023 1

Text availability

Article attribute

Article type

Publication date

Search Results

188 results

Results by year

Filters applied: Meta-Analysis, Randomized Controlled Trial. Clear all
Page 1
Phosphate binders for preventing and treating chronic kidney disease-mineral and bone disorder (CKD-MBD).
Ruospo M, Palmer SC, Natale P, Craig JC, Vecchio M, Elder GJ, Strippoli GF. Ruospo M, et al. Cochrane Database Syst Rev. 2018 Aug 22;8(8):CD006023. doi: 10.1002/14651858.CD006023.pub3. Cochrane Database Syst Rev. 2018. PMID: 30132304 Free PMC article.
BACKGROUND: Phosphate binders are used to reduce positive phosphate balance and to lower serum phosphate levels for people with chronic kidney disease (CKD) with the aim to prevent progression of chronic kidney disease-mineral and bone disorder (CKD-MBD). ... …
BACKGROUND: Phosphate binders are used to reduce positive phosphate balance and to lower serum phosphate levels for peo …
Interventions for rosacea.
van Zuuren EJ, Fedorowicz Z, Carter B, van der Linden MM, Charland L. van Zuuren EJ, et al. Cochrane Database Syst Rev. 2015 Apr 28;2015(4):CD003262. doi: 10.1002/14651858.CD003262.pub5. Cochrane Database Syst Rev. 2015. PMID: 25919144 Free PMC article. Review.
There was no rebound or worsening of erythema after treatment cessation.Topical clindamycin phosphate combined with tretinoin was not considered to be effective compared to placebo (moderate quality evidence).Topical ciclosporin ophthalmic emulsion demonstrated effectivene …
There was no rebound or worsening of erythema after treatment cessation.Topical clindamycin phosphate combined with tretinoin was not …
Efficacy, safety, and immunogenicity of an inactivated, adjuvanted enterovirus 71 vaccine in infants and children: a multiregion, double-blind, randomised, placebo-controlled, phase 3 trial.
Nguyen TT, Chiu CH, Lin CY, Chiu NC, Chen PY, Le TTV, Le DN, Duong AH, Nguyen VL, Huynh TN, Truong HK, Phan TL, Nguyen TTT, Shih SR, Huang CG, Weng YJ, Hsieh EF, Chang S, Chen C, Tai IC, Huang LM. Nguyen TT, et al. Lancet. 2022 Apr 30;399(10336):1708-1717. doi: 10.1016/S0140-6736(22)00313-0. Epub 2022 Apr 12. Lancet. 2022. PMID: 35427481 Clinical Trial.
We aimed to evaluate the efficacy, safety, and immunogenicity of EV71vac, an aluminium phosphate-adjuvanted inactivated EV71 vaccine in children aged 2-71 months. ...
We aimed to evaluate the efficacy, safety, and immunogenicity of EV71vac, an aluminium phosphate-adjuvanted inactivated EV71 v …
Effect of aluminium phosphate on the bioavailability of cimetidine and prednisolone.
Albin H, Vincon G, Demotes-Mainard F, Begaud B, Bedjaoui A. Albin H, et al. Eur J Clin Pharmacol. 1984;26(2):271-3. doi: 10.1007/BF00630299. Eur J Clin Pharmacol. 1984. PMID: 6723769 Clinical Trial.
Ten fasting subjects received 200 mg cimetidine orally either with water or 11 g aluminium phosphate mixture in a randomized, single dose, two-way cross-over study. ...There were no significant differences in the values of area under curve (AUC), Cmax and tmax. The …
Ten fasting subjects received 200 mg cimetidine orally either with water or 11 g aluminium phosphate mixture in a randomized, …
Effect of RenaGel, a non-absorbed, calcium- and aluminium-free phosphate binder, on serum phosphorus, calcium, and intact parathyroid hormone in end-stage renal disease patients.
Goldberg DI, Dillon MA, Slatopolsky EA, Garrett B, Gray JR, Marbury T, Weinberg M, Wombolt D, Burke SK. Goldberg DI, et al. Nephrol Dial Transplant. 1998 Sep;13(9):2303-10. doi: 10.1093/ndt/13.9.2303. Nephrol Dial Transplant. 1998. PMID: 9761513 Clinical Trial.
Efficacy of currently available calcium- and aluminium-containing phosphate binders is constrained by the side-effects associated with the absorption of calcium and aluminium. ...METHODS: Administration of calcium- or aluminium-containing phosphate …
Efficacy of currently available calcium- and aluminium-containing phosphate binders is constrained by the side-effects associa …
Double-blind randomized, multicenter study comparing aluminium phosphate gel with rantitidine in the short-term treatment of duodenal ulcer.
Parente F, Bianchi Porro G, Canali A, Bensi G. Parente F, et al. Hepatogastroenterology. 1995 Apr;42(2):95-9. Hepatogastroenterology. 1995. PMID: 7672773 Clinical Trial.
The efficacy and safety of aluminium phosphate and ranitidine in the short-term treatment of duodenal ulcer were compared in a multicenter, randomized, double-blind study. ...At the end of the treatment period, 74 out of 113 patients (65%) treated with aluminium …
The efficacy and safety of aluminium phosphate and ranitidine in the short-term treatment of duodenal ulcer were compared in a …
Efficacy and safety of lanthanum carbonate versus calcium-based phosphate binders in patients with chronic kidney disease: a systematic review and meta-analysis.
Zhai CJ, Yang XW, Sun J, Wang R. Zhai CJ, et al. Int Urol Nephrol. 2015 Mar;47(3):527-35. doi: 10.1007/s11255-014-0876-x. Epub 2014 Nov 16. Int Urol Nephrol. 2015. PMID: 25399356 Review.
Lanthanum carbonate appeared to be associated with a significant reduction in progression of vascular calcification and a beneficial effect on bone outcomes without aluminum-like toxicity. Lanthanum carbonate achieved similar proportions of phosphate-controlled pati …
Lanthanum carbonate appeared to be associated with a significant reduction in progression of vascular calcification and a beneficial effect …
Suppression of secondary hyperparathyroidism in children with chronic renal failure by high dose phosphate binders: calcium carbonate versus aluminium hydroxide.
Mak RH, Turner C, Thompson T, Powell H, Haycock GB, Chantler C. Mak RH, et al. Br Med J (Clin Res Ed). 1985 Sep 7;291(6496):623-7. doi: 10.1136/bmj.291.6496.623. Br Med J (Clin Res Ed). 1985. PMID: 3928054 Free PMC article. Clinical Trial.
Secondary hyperparathyroidism was suppressed over a period of one year in 12 children with chronic renal failure by using a regimen of mild dietary phosphate restriction and high dose phosphate binders. The patients were randomised to receive either aluminium …
Secondary hyperparathyroidism was suppressed over a period of one year in 12 children with chronic renal failure by using a regimen of mild …
Comparison of calcium carbonate and aluminium hydroxide as phosphate binders on biochemical bone markers, PTH(1-84), and bone mineral content in dialysis patients.
Jespersen B, Jensen JD, Nielsen HK, Lauridsen IN, Andersen MJ, Poulsen JH, Gammelgaard B, Pedersen EB. Jespersen B, et al. Nephrol Dial Transplant. 1991;6(2):98-104. doi: 10.1093/ndt/6.2.98. Nephrol Dial Transplant. 1991. PMID: 1857534 Clinical Trial.
Bone mineral content, estimated by single-photon absorptiometry of the forearm, serum values of intact parathyroid hormone (PTH(1-84], osteocalcin, alkaline phosphatase, 1,25-dihydroxycholecalciferol (1,25(OH)2D3), and aluminium were determined during treatment with calciu …
Bone mineral content, estimated by single-photon absorptiometry of the forearm, serum values of intact parathyroid hormone (PTH(1-84], osteo …
188 results

Searches related to "aluminium phosphate"